Oceanit readies rapid COVID-19 test developed in Hawaii for FDA approval
A COVID-19 saliva test developed in Hawaii and ranging in price from $5 to $20 could be approved by the U.S. Food and Drug Administration within weeks, although it could be months before it’s widely available.
Oceanit Laboratories founder and CEO Pat Sullivan told the Honolulu Star- Advertiser’s Spotlight Hawaii on Friday that the test, which looks similar to a pregnancy test, is in the final stages of validating, with the biotech company aiming to get an application in to the FDA by the end of the month.
The rapid test, which could be used in schools, businesses and other settings and to ensure the safety of visitors coming into the islands, provides results in three to 10 minutes.
“We’re hopefully weeks away from FDA approval. If we get approval at the end of the month, it’ll take us months to kind of get up and running,” Sullivan said. “What we’re trying to do is find some ways to go faster in spurts so that we can start producing for some of the local businesses and the folks who could really use the test.”
Also Friday, state officials reported one new coronavirus death on Oahu and 89 new infections statewide, bringing the totals since the start of the pandemic to 185 fatalities and 13,853 cases. The latest death was an Oahu woman over age 80 with an underlying medical condition.
The state Health Department has yet to verify a number of deaths related to the new coronavirus. As ...
More on: www.staradvertiser.com